Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Johannesburg Stock Exchange  >  Aspen Pharmacare Holdings Limited    APNJ   ZAE000066692

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Johannesburg Stock Exchan…
10/17/2017 10/18/2017 10/19/2017 10/20/2017 10/23/2017 Date
315.83 320.29 319.51 317.37 323.12 Last
1064230 1094654 535246 699165 723748 Volume
-1.92% +1.41% -0.24% -0.67% +1.81% Change
Financials ( ZAR)
Sales 2018 45 814 M
EBIT 2018 11 678 M
Net income 2018 7 841 M
Debt 2018 39 179 M
Yield 2018 1,08%
Sales 2019 49 326 M
EBIT 2019 13 006 M
Net income 2019 9 042 M
Debt 2019 36 182 M
Yield 2019 1,20%
P/E ratio 2018 18,12
P/E ratio 2019 16,00
EV / Sales2018 4,02x
EV / Sales2019 3,67x
Capitalization 145 B
More Financials
Company
Aspen Pharmacare Holdings Ltd. engages in the manufacture and supply of branded and generic pharmaceutical products.The firm operates through the following segments: International, South Africa, Asia Pacific, and Sub-Saharan Africa.Its products include anaesthetics, analgesics, antiretrovirals,... 
Sector
Pharmaceuticals
Calendar
11/22Investor Day
More about the company
Surperformance© ratings of Aspen Pharmacare Holdings
Trading Rating : Investor Rating :
More Ratings
Latest news on ASPEN PHARMACARE HOLDINGS
10/16 ASPEN PHARMACARE : UK anti-trust regulator investigates SA’s Aspen Pharmac..
10/13 ASPEN PHARMACARE : UK anti-trust regulator investigates South Africa's Aspen Pha..
10/06 Aspen and Equity probes halt
10/04 ASPEN PHARMACARE HOLDINGS LIMITED : ex-dividend day for annual dividend
09/18 ASPEN PHARMACARE : Hits & Misses. Hits. Tshabalala leads Standard alone but SA b..
09/16 Aspen Pharmacare posts 46% profit jump
09/14 ASPEN PHARMACARE : buys remaining rights to AstraZeneca’s anesthetics
09/14 ASPEN PHARMACARE : buys remaining rights to AstraZeneca’s anesthetics
09/11ASPEN PHARMACARE HOLDINGS LIMITED : annual earnings release
08/22 ASPEN PHARMACARE : STOCK WATCH. Aspen hurt by ill winds lashing sector
More news
Sector news : Generic Pharmaceuticals
10/23 European stocks hold firm as banks, Spanish shares fall
10/23 Smith & Nephew to buy Rotation Medical for up to $210 million
10/23DJEuropean Corporate Roundup for Monday
10/23DJDrug Makers Find 'Branded Generics' Are a Source for Growth
10/23 ASTRAZENECA : among backers as Swiss cancer biotech raises $200 million
More sector news : Generic Pharmaceuticals
Latest Tweets
10/13UK anti-trust regulator investigates South Africa's Aspen Pharmacare  
10/13UK anti-trust regulator investigates South Africa's Aspen Pharmacare  
09/07European ICU Sedation Drugs Market - Forecasts to 2021 - Key Players are Aspe.. 
09/07European ICU Sedation Drugs Market - Forecasts to 2021 - Key Players are Aspe.. 
09/07European ICU Sedation Drugs Market - Forecasts to 2021 - Key Players are Aspe.. 
More tweets
Qtime:47
News from SeekingAlpha
05/17 Aspen Pharmacare Has Continued To Grow And Branch Out
2016 Wobbles Aside, Small Pharma Shares Broadly On The Up In 2015
2015 Sector's Smaller Players Show The Way
2015 OPPORTUNITIES AND RISKS IN THE BIOTE : 2 Companies In South Africa
2015 SEEKING ALPHA'S BIOTECH WEEKLY : Deeper Looks At Orexigen, Pharmacyclics, And Ac..
Chart ASPEN PHARMACARE HOLDINGS
Duration : Period :
Aspen Pharmacare Holdings  Technical Analysis Chart | APNJ | ZAE000066692 | 4-Traders
Technical analysis trends ASPEN PHARMACARE HOLDINGS
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 332  ZAR
Spread / Average Target 4,7%
EPS Revisions
Managers
NameTitle
Stephen Bradley Saad Group Chief Executive Officer & Executive Director
Douglas Dlamini Chairman
Lorraine Hill Group Operating Officer
Sean Capazorio Group Finance Officer
Michael Guy Attridge Executive Director & Group Deputy CEO
Sector and Competitors